Is colorectal cancer screening feasible and useful?;Le depistage du cancer colique est-il possible et utile?

Gastroenterologie Clinique et Biologique

Volumn 22, Issue 3 BIS, 1998, Pages

  Tazi, Mohammed Adnane ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Colonic cancer; Cost effectiveness; Endoscopy; Faecal occult blood test; High risk group; Mass screening; Population

Indexed keywords

ANAMNESIS; CANCER SCREENING; COLON POLYPOSIS; COLORECTAL CANCER; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ENTERITIS; FAMILIAL POLYPOSIS; HIGH RISK POPULATION; HUMAN; MASS SCREENING; SCREENING TEST; ARTICLE; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; RISK FACTOR;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 0032013624     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Eddy DM. Secondary prevention of cancers: an overview. Bull World Health Org 1986;64:421-9.
2. Menegoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buemi A, et al. Cancer incidence and mortality in France in 1975-1995. Eur J Cancer Prev 1997;6:442-66.
3. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of cancer patients in Europe. The EUROCARE study. IARC SCI publ no 132. Lyon: IARC, 1995.
4. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with fecal occult blood test at Funen in Denmark. Lancet 1996;348:1467-71.
5. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472-7.
6. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989;24:599-606.
7. Hardcastle JD, Thomas WH, Chamberlain J. Pye G, Sheffield J, James PD, et al. Randomised controlled trial of a faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1989;1:1160-4.
8. Launoy G, Valla A, Reaud JM, Thésée Y, Ollivier V, Herbert C, et al. Résultats du premier dépistage de masse du cancer colorectal auprès de 154 789 personnes dans le département du Calvados. Participation de la population et résultats médicaux (résumé). Gastroenterol Clin Biol 1995;19:A41.
9. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity and predictive value. Ann Intern Med 1990;112:328-33.
10. Mandel JS, Bond JH, Bradley M, Snover DC, Church TR, Williams S, et al. Sensitivity, specificity and positive predictivity of the Hemoccult test in screening for colorectal cancers. The university of Minnesota's colon cancer control study. Gastroenterology 1989;97:597-600.
11. Bertario L, Spinelli P, Gennari L, Sala P, Pizzetti P, Severini A, et al. Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci 1988;33:609-13.
12. Macrae FA, St John DJB: Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-8.
13. St John JB, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104: 1661-8.
14. Joseph AM, Crowson TW, Rich EC. Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening. J Gen Intern Med 1988;3:132-8.
15. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. Ann Intern Med 1993;118:1-6.
16. Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995;61:465-9.
17. Lazovich D, Weiss NS, Stevens NG, White E. McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screening 1995;2:84-9.
18. Warhendorf J, Robra BP, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control study in Saarland, Germany. Eur J Cancer Prev 1993;2:221-7.
19. Gnauck R. Screening for cancer in Germany. Tumori 1995;81 (suppl):30-7.
20. Mandel JS, Dond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
21. Lang CA, Ransohoff DF, Facal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy ? JAMA 1994;271:1011-13.
22. Mandel JS, Ederer F, Church T, Bond J. Screening for colorectal cancer: Which test is best. JAMA 1994;272:1099.
23. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27700 subjects. Cancer 1988;62:645-51.
24. Tazi MA, Faivre J, Dassonville F, Lamour J, Milan C, Faivre J. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results for five sceening rounds from 1988 to 1996. J Med Screening 1997;4:147-51.
25. Launoy G, Herbert C, Vallée JP, Desoubeaux N, Reaud J-M, Ollivier V, et al. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165 000 personnes dans le Calvados. Gastroenterol Clin Biol 1996;20:228-36.
26. Arveux P, Durand G, Milan C, Bedenne L, Lèvy D, Doan BDH, et al. Views of a general population on mass screening for colorectal cancer: the Burgundy study. Prev Med 1992;21:574-81.
27. Harrinton LJ, Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Case-control study of digital-rectal screening in relation to mortality from cancer of distal rectum. Am J Epidemiol 1995;142:961-4.
28. Newcomb PA, Norfleet RG, Storer BE, Surawicz T, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
29. Selby JV, Friedman GD, Qeusenberry CP Jr, Weis NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
30. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32, 702 veterans. Ann Intern Med 1995;123:904-10.
31. Hoff G, Vatn M, Gjone E, Larsen S, Sauar J. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol 1985;20:351-5.
32. Burt RW, Groden J. The genetic and molecular diagnosis of adenomatous polyposis coli. Gastroenterology 1993;104:1211-4.
33. Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JK, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993;90:2846-50.
34. Lanspa SJ, Lynch HT, Smyrk TC, Strayhom P, Watson P, Lynch JF, et al. Colorectal adenomas in the Lynch syndromes. Gastroenterology 1990;98:1117-22.
35. Jarvinen HJ. Time and type of prophylactic surgery for familial adenomatosis coli. Ann Surg 1985;202:93-7.
36. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
37. Boutron MC, Faivre J, Quipourt V, Senesse P, Michiels C. Family history of colorectal tumours and implications for the adenomacarcinoma sequence: a case-control study. Gut 1995;37:830-4.
38. St John DJB, McDermott FT, Hopper JL, Debney EA, Johnsn WR, Hughes ESR. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
39. Bonelli L, Martines H, Conio M, Bruzzi P, Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 1988;41:513-7.
40. Kune GA, Kune S, Waston LF. The Melbourne colorectal cancer study. Characterization of patients with a family history of colorectal cancer. Dis Colon Rectum 1987;30:600-6.
41. Maire P, Morichau-Beauchant M, Drucker J, Barboteau M-A, Barbier J, Matuchansky C. Prévalence familiale du cancer du côlon et du rectum: résultats d'une enquête cas-témoins de 3 ans. Gastroenterol Clin Biol 1984;8:22-7.
42. Duncan JL, Kyle J. Family incidence of carcinoma of the colon and rectum in North-East Scotland. Gut 1982;23:169-71.
43. Houlston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. Br Med J 1990;301:366-8.
44. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74.
45. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Cynthia D, et al. Colorectal cancer screening and surveillance: Clinical Guidelines and Rationale. Gastroenerology 1997;112:594-642.
46. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334:82-7.
47. Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993;36:388-93.
48. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
49. Jorgensen OD, Kronberg O, Fenger C. The Funen adenoma follow-up study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993;28:869-74.
50. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
51. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901-6.
52. Lieberman DA. Cost-effectiveness model for colon cancer screening Gastrocnterology 1995;109:1781-90.
53. Gyrd-Hansen D, Sogaard J, Kronborg O. Colorectal cancer screening: efficiency and effectiveness. Health Economics 1998, in Press.
54. Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effetiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rosen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: W.B. Saunders, 1996;321-41.
55. Eddy DM, Nugent FW, Eddy JF, Coller J, Gilbertsen V, Gottlieb LS, et al. Screening for colorectal cancer in high-risk population. Results of a mathematical model. Gastroenterology 1987;92:682-92.